
  
    
      
        
        There_EX has_VBZ been_VBN a_DT recent_JJ and_CC dramatic_JJ rise_NN in_IN global_JJ funding_NN for_IN HIV_NNP /_NN AIDS_NNP ,_, from_IN US_NNP $_$ 2_CD ._. 1_LS
        billion_CD in_IN 2001_CD to_TO US_NNP $_$ 6_CD ._. 1_LS billion_CD in_IN 2004_CD [_NN 1_CD ]_NN ,_, thanks_NNS to_TO several_JJ new_JJ funding_NN mechanisms_NNS
        (_( Box_NNP 1_LS )_) ._. These_DT funds_NNS ,_, coupled_VBN with_IN reduced_VBN drug_NN costs_NNS ,_, make_VB it_PRP feasible_JJ to_TO roll_VB out_IN
        antiretroviral_NN therapy_NN (_( ART_NNP )_) even_RB in_IN resource-poor_JJ settings_NNS ._. Nevertheless_RB ,_, the_DT total_JJ number_NN
        of_IN people_NNS living_VBG with_IN HIV_NNP rose_VBD in_IN 2004_CD to_TO reach_VB its_PRP$ highest_JJS level_NN ever_RB :_: an_DT estimated_VBN 39_CD ._. 4_LS
        million_CD people_NNS are_VBP living_VBG with_IN the_DT virus_NN ,_, including_VBG 4_CD ._. 9_CD million_CD who_WP acquired_VBD it_PRP in_IN 2004_CD
        [_NN 1_CD ]_NN ._. Therefore_RB ,_, the_DT debate_NN over_IN the_DT appropriate_JJ distribution_NN of_IN money_NN between_IN prevention_NN
        efforts_NNS (_( such_JJ as_IN voluntary_JJ counseling_NN and_CC testing_NN [_NN VCT_NNP ]_NN ,_, or_CC behavior_NN change_NN )_) and_CC treatment_NN
        efforts_NNS (_( the_DT provision_NN of_IN ART_NNP )_) is_VBZ now_RB more_RBR topical_JJ than_IN ever_RB ._.
      
      
        Balancing_NNP Prevention_NNP and_CC Treatment_NNP
        The_DT scale_NN of_IN the_DT proposed_VBN increase_NN in_IN the_DT number_NN of_IN patients_NNS receiving_VBG ART_NNP raises_VBZ
        numerous_JJ questions_NNS about_IN the_DT treatment_NN itself_PRP ._. Which_WDT drugs_NNS will_MD be_VB used_VBN ?_. How_WRB much_JJ will_MD it_PRP
        cost_VBD ?_. How_WRB will_MD their_PRP$ quality_NN be_VB monitored_VBN and_CC assured_VBN ?_. How_WRB will_MD they_PRP be_VB distributed_VBN ?_. Who_WP
        will_MD be_VB eligible_JJ ?_. How_WRB will_MD the_DT desired_VBN level_NN of_IN treatment_NN be_VB sustained_VBN ?_. Is_VBZ there_EX adequate_JJ
        infrastructure_NN and_CC human_JJ resources_NNS to_TO support_VB the_DT expanded_VBN services_NNS ?_.
        The_DT commitment_NN of_IN substantial_JJ funding_NN to_TO treatment_NN in_IN resource-poor_JJ countries_NNS also_RB has_VBZ
        implications_NNS for_IN the_DT prevention_NN efforts_NNS in_IN those_DT same_JJ countries_NNS ._. In_IN many_JJ Western_JJ countries_NNS
        and_CC Brazil_NNP (_( the_DT sources_NNS of_IN the_DT majority_NN of_IN the_DT available_JJ data_NN on_IN the_DT subject_JJ )_) ,_, the_DT
        impressive_JJ drop_NN in_IN mortality_NN due_JJ to_TO HIV_NNP following_VBG increased_VBN access_NN to_TO ART_NNP is_VBZ coupled_VBN with_IN a_DT
        disheartening_VBG rise_NN in_IN the_DT number_NN of_IN new_JJ cases_NNS of_IN HIV_NNP ,_, as_IN emphasis_NN and_CC funding_NN are_VBP shifted_VBN
        from_IN prevention_NN to_TO treatment_NN [_NN 2_CD ]_NN ._. Countries_NNS in_IN which_WDT this_DT pattern_NN has_VBZ been_VBN seen_VBN are_VBP
        evidence_NN of_IN the_DT pitfalls_NNS of_IN failing_VBG to_TO adapt_VB prevention_NN efforts_NNS once_RB life-extending_JJ
        treatment_NN becomes_VBZ widely_RB available_JJ ._.
        Of_IN course_NN ,_, prevention_NN and_CC treatment_NN are_VBP not_RB mutually_RB exclusive_JJ ._. Successful_JJ prevention_NN
        efforts_NNS mean_VBP fewer_JJR patients_NNS will_MD need_VB the_DT costly_JJ drug_NN treatment_NN programs_NNS ,_, helping_VBG extend_VB
        the_DT sustainability_NN of_IN ART_NNP ._. In_IN turn_NN ,_, the_DT success_NN of_IN ART_NNP in_IN prolonging_VBG healthy_JJ living_NN helps_VBZ
        prevention_NN efforts_NNS by_IN reducing_VBG the_DT stigma_NN associated_VBN with_IN self-education_JJ and_CC responsible_JJ
        behaviors_NNS ._.
      
      
        Measuring_NN Prevention_NNP and_CC Treatment_NNP Effects_NNPS
        In_IN their_PRP$ study_NN in_IN the_DT January_NNP 2005_CD issue_NN of_IN 
        PLoS_NNP Medicine_NNP ,_, “ Integrating_NNP HIV_NNP Prevention_NNP and_CC Treatment_NNP :_: From_IN Slogans_NNP
        to_TO Impact_NNP ,_,” Salomon_NNP and_CC colleagues_NNS use_VBP mathematical_JJ modeling_NN to_TO assess_VB the_DT epidemiologic_JJ
        impact_NN of_IN treatment_NN and_CC prevention_NN efforts_NNS ,_, and_CC to_TO quantify_VB the_DT opportunities_NNS and_CC potential_JJ
        risks_NNS of_IN large-scale_JJ treatment_NN roll-out_NN ._. Using_VBG a_DT variety_NN of_IN different_JJ scenarios_NNS ,_, they_PRP
        propose_VBP methods_NNS for_IN establishing_VBG the_DT most_RBS effective_JJ balance_NN between_IN spending_NN on_IN prevention_NN
        and_CC spending_NN on_IN treatment_NN ._.
        Modeling_NNP is_VBZ a_DT technique_NN used_VBN by_IN many_JJ scientists_NNS ,_, including_VBG epidemiologists_NNS and_CC
        statisticians_NNS ,_, to_TO create_VB a_DT mathematical_JJ equation_NN that_WDT can_MD be_VB used_VBN to_TO determine_VB which_WDT
        variables_NNS affect_VBP an_DT outcome_NN of_IN interest_NN ,_, and_CC to_TO what_WP extent_NN ._. Once_RB the_DT influential_JJ variables_NNS
        are_VBP determined_VBN ,_, a_DT baseline_NN model_NN is_VBZ established_VBN that_WDT includes_VBZ those_DT variables_NNS and_CC reflects_VBZ
        their_PRP$ relative_JJ importance_NN to_TO the_DT outcome_NN ._. The_DT effect_NN of_IN changing_VBG the_DT value_NN of_IN any_DT of_IN these_DT
        variables_NNS ,_, or_CC several_JJ of_IN them_PRP ,_, can_MD then_RB be_VB tested_VBN ,_, and_CC new_JJ outcomes_NNS projected_VBN ._. HIV_NNP modeling_NN
        is_VBZ inexact_NN and_CC requires_VBZ far_RB better_JJR data_NNS but_CC can_MD nevertheless_RB provide_VB important_JJ
        insights_NNS ._.
        Salomon_NNP and_CC colleagues_NNS used_VBD mathematical_JJ modeling_NN to_TO assess_VB the_DT effect_NN of_IN changing_VBG
        aspects_NNS of_IN the_DT HIV_NNP /_NN AIDS_NNP “ equation_NN” on_IN the_DT future_JJ course_NN of_IN the_DT HIV_NNP /_NN AIDS_NNP epidemic_NN ._. First_LS ,_, a_DT
        baseline_NN model_NN was_VBD created_VBN to_TO fit_VB expected_VBN HIV_NNP /_NN AIDS_NNP projections_NNS for_IN the_DT year_NN 2020_CD if_IN there_EX
        were_VBD to_TO be_VB no_DT change_NN in_IN the_DT current_JJ epidemiologic_JJ trends—no_NN ART_NNP scale-up_JJ ,_, and_CC no_DT changes_NNS in_IN
        prevention_NN efforts_NNS or_CC behavior_NN ._. Heterosexual_NNP contact_NN is_VBZ the_DT predominant_NN mode_NN of_IN HIV_NNP
        transmission_NN across_IN Africa_NNP ,_, and_CC Salomon_NNP and_CC colleagues_NNS '_POS study_NN modeled_VBD the_DT disease_NN only_RB
        within_IN the_DT heterosexual_NN population_NN ._. The_DT model_NN was_VBD also_RB tailored_VBN to_TO take_VB into_IN account_NN
        epidemiologic_JJ ,_, demographic_JJ ,_, and_CC sociologic_JJ patterns_NNS in_IN the_DT eastern_JJ ,_, central_JJ /_NN western_JJ and_CC
        southern_JJ regions_NNS of_IN Africa_NNP ._. Using_VBG the_DT baseline_NN models_NNS tailored_VBN to_TO each_DT region_NN ,_, the_DT effects_NNS
        of_IN prevention_NN and_CC treatment_NN efforts_NNS were_VBD then_RB measured_VBN ._.
        Two_CD treatment-centered_JJ scenarios_NNS were_VBD tested_VBN in_IN which_WDT the_DT World_NNP Health_NNP Organization_NNP 's_POS “ 3_CD
        by_IN 5_CD” initiative_NN (_( see_VB Box_NNP 1_LS )_) was_VBD achieved_VBN ._. In_IN these_DT treatment-centered_JJ scenarios_NNS ,_, the_DT
        reduction_NN of_IN transmissibility_NN ,_, the_DT number_NN of_IN partners_NNS of_IN each_DT patient_NN ,_, and_CC condom_NN use_NN were_VBD
        either_CC optimal_NN (_( reduced_VBN transmissibility_NN ,_, reduced_VBN partners_NNS ,_, and_CC increased_VBD condom_NN use_NN )_) or_CC
        less_JJR than_IN optimal_NN ._. The_DT prevention-centered_JJ scenario_NN tested_VBD the_DT impact_NN of_IN a_DT comprehensive_JJ
        package_NN of_IN 12_CD prevention_NN tools_NNS (_( such_JJ as_IN VCT_NNP and_CC peer_VBP counseling_NN for_IN sex_NN workers_NNS )_) ,_, modeling_NN
        only_RB partial_JJ effectiveness_NN at_IN the_DT population_NN level_NN ,_, to_TO reflect_VB weaker_JJR political_JJ and_CC social_JJ
        support_NN for_IN HIV_NNP control_NN efforts_NNS ._. Finally_RB ,_, combined_VBN response_NN scenarios_NNS were_VBD tested_VBN ._. In_IN the_DT
        first_JJ scenario_NN ,_, treatment_NN efforts_NNS strengthened_VBD prevention_NN efforts_NNS as_IN ,_, for_IN example_NN ,_, when_WRB the_DT
        availability_NN of_IN ART_NNP increases_VBZ people_NNS 's_POS willingness_NN to_TO undergo_VB testing_NN ._. In_IN the_DT second_NN ,_, an_DT
        emphasis_NN on_IN treatment_NN led_VBN to_TO less_RBR effective_JJ implementation_NN of_IN prevention_NN efforts_NNS ._.
        Baseline_NNP projections_NNS in_IN Salomon_NNP and_CC colleagues_NNS '_POS study_NN showed_VBD that_IN without_IN any_DT behavioral_JJ
        change_NN or_CC ART_NNP scale-up_JJ ,_, the_DT HIV_NNP /_NN AIDS_NNP prevalence_NN rate_NN would_MD remain_VB relatively_RB stable_JJ ,_, but_CC
        the_DT number_NN of_IN new_JJ infections_NNS would_MD increase_VB by_IN 52_CD ._. 3_LS million_CD by_IN 2020_CD ._. Treatment-centered_NNP
        scenarios_NNS reduced_VBD the_DT total_JJ number_NN of_IN new_JJ infections_NNS through_IN 2020_CD by_IN a_DT maximum_NN of_IN 3_CD
        million_CD ,_, or_CC 6_CD %_NN ,_, while_IN indicating_VBG that_IN the_DT number_NN of_IN AIDS_NNP deaths_NNS through_IN 2020_CD would_MD decline_VB
        by_IN 13_CD %_NN ,_, to_TO 32_CD ._. 4_LS million_CD ._. A_DT prevention-centered_JJ strategy_NN would_MD provide_VB greater_JJR reductions_NNS in_IN
        incidence_NN (_( 36_CD %_NN )_) and_CC similar_JJ mortality_NN reductions_NNS by_IN 2020_CD ,_, but_CC more_RBR modest_JJ mortality_NN
        benefits_NNS over_IN the_DT next_JJ five_CD to_TO ten_CD years_NNS ._.
        The_DT scenarios_NNS in_IN which_WDT all_DT of_IN these_DT statistics_NNS were_VBD most_RBS improved_VBN ,_, however_RB ,_, were_VBD those_DT
        that_WDT combined_VBD both_DT prevention_NN and_CC treatment_NN efforts_NNS ._. In_IN the_DT scenario_NN in_IN which_WDT treatment_NN
        enhanced_JJ prevention_NN ,_, Salomon_NNP and_CC colleagues_NNS projected_VBD 29_CD million_CD averted_VBN infections_NNS (_( 55_CD %_NN )_)
        and_CC 10_CD million_CD averted_VBN deaths_NNS (_( 27_CD %_NN )_) through_IN the_DT year_NN 2020_CD ._. However_RB ,_, if_IN a_DT narrow_JJ focus_NN on_IN
        treatment_NN scale-up_JJ leads_VBZ to_TO reduced_VBN effectiveness_NN of_IN prevention_NN efforts_NNS ,_, the_DT benefits_NNS of_IN a_DT
        combined_VBN response_NN would_MD be_VB considerably_RB smaller—_NN 9_CD million_CD averted_VBN infections_NNS (_( 17_CD %_NN )_) and_CC 6_CD
        million_CD averted_VBN deaths_NNS (_( 16_CD %_NN )_) (_( Figure_NN 1_LS )_) ._.
        Combining_NNP treatment_NN with_IN effective_JJ prevention_NN efforts_NNS could_MD reduce_VB the_DT resource_NN needs_VBZ
        for_IN treatment_NN dramatically_RB in_IN the_DT long_JJ term_NN ._. In_IN the_DT various_JJ scenarios_NNS the_DT numbers_NNS of_IN people_NNS
        being_VBG treated_VBN in_IN 2020_CD ranges_NNS from_IN 9_CD ._. 2_CD million_CD in_IN a_DT treatment-only_JJ scenario_NN with_IN mixed_JJ
        effects_NNS ,_, to_TO 4_CD ._. 2_CD million_CD in_IN a_DT combined_VBN response_NN with_IN positive_JJ treatment–prevention_NN
        synergies_NNS ._.
      
      
        Moving_VBG Forward_NNP
        The_DT authors_NNS have_VBP demonstrated_VBN through_IN mathematical_JJ modeling_NN that_IN the_DT integration_NN of_IN
        treatment_NN and_CC prevention_NN is_VBZ epidemiologically_RB sound_NN ._. However_RB ,_, an_DT integrated_VBN and_CC
        comprehensive_JJ program_NN (_( Figure_NN 2_LS )_) is_VBZ not_RB only_RB logical_JJ but_CC makes_VBZ sense_NN from_IN the_DT service_NN
        delivery_NN point_NN of_IN view_NN :_: it_PRP can_MD be_VB cost-effective_JJ and_CC ideal_JJ for_IN the_DT community_NN ._.
        
        Effective_NNP prevention_NN makes_VBZ treatment_NN more_RBR affordable_JJ and_CC
        sustainable_JJ ._. Effective_NNP prevention_NN can_MD lead_VB to_TO a_DT substantial_JJ reduction_NN in_IN the_DT number_NN of_IN
        new_JJ infections_NNS and_CC therefore_RB ultimately_RB will_MD lead_VB to_TO a_DT reduction_NN in_IN the_DT number_NN of_IN people_NNS
        who_WP will_MD need_VB treatment_NN ._. The_DT reduction_NN of_IN adult_NN HIV_NNP /_NN AIDS_NNP prevalence_NN in_IN Uganda_NNP from_IN 18_CD ._. 5_LS %_NN to_TO
        6_CD %_NN over_IN the_DT last_JJ several_JJ years_NNS has_VBZ reduced_VBN the_DT number_NN of_IN those_DT eventually_RB needing_VBG treatment_NN
        by_IN nearly_RB 68_CD %_NN [_NN 3_CD ]_NN ._. Unless_IN the_DT incidence_NN of_IN HIV_NNP is_VBZ sharply_RB reduced_VBN ,_, HIV_NNP treatment_NN will_MD not_RB
        be_VB able_JJ to_TO keep_VB pace_NN with_IN all_PDT those_DT who_WP will_MD need_VB therapy_NN [_NN 4_CD ]_NN ._. Salomon_NNP and_CC colleagues_NNS '_POS
        reaffirmation_NN that_IN only_RB effective_JJ prevention_NN will_MD make_VB treatment_NN affordable_JJ is_VBZ critically_RB
        important_JJ ._.
        
        Successful_JJ treatment_NN and_CC care_NN can_MD make_VB prevention_NN more_RBR acceptable_JJ and_CC
        effective_JJ ._. Widespread_NNP access_NN to_TO treatment_NN could_MD bring_VB millions_NNS of_IN people_NNS into_IN
        health-care_NN settings_NNS ,_, providing_VBG new_JJ opportunities_NNS for_IN health-care_NN workers_NNS to_TO deliver_VB and_CC
        reinforce_VB HIV_NNP prevention_NN messages_NNS and_CC interventions_NNS [_NN 4_CD ]_NN ._. Improved_JJ access_NN to_TO HIV_NNP testing_NN
        provides_VBZ an_DT entry_NN point_NN to_TO both_DT prevention_NN and_CC treatment_NN services_NNS and_CC provides_VBZ a_DT unique_JJ
        opportunity_NN to_TO identify_VB and_CC target_VB the_DT infected_JJ ,_, vulnerable_JJ ,_, and_CC uninfected_JJ with_IN more_RBR
        appropriate_JJ interventions_NNS ._. All_DT health-care_NN settings_NNS ,_, including_VBG HIV_NNP treatment_NN sites_NNS ,_, should_MD
        deliver_VB HIV_NNP prevention_NN services_NNS [_NN 4_CD ]_NN ._.
        
        Prevention_NNP can_MD make_VB treatment_NN more_RBR accessible_JJ ._. The_DT early_JJ establishment_NN of_IN
        community-based_JJ prevention_NN services_NNS in_IN rural_JJ Ghana_NNP was_VBD instrumental_JJ in_IN reducing_VBG the_DT stigma_NN
        of_IN AIDS_NNP and_CC improving_VBG the_DT knowledge_NN and_CC attitude_NN of_IN the_DT community_NN prior_RB to_TO the_DT development_NN
        of_IN ART_NNP and_CC VCT_NNP services_NNS (_( K_NNP ._. Torpey_NNP ,_, personal_JJ communication_NN )_) ._. This_DT process_NN also_RB made_VBD it_PRP
        easier_JJR for_IN community_NN and_CC implementing_VBG agencies_NNS to_TO identify_VB and_CC refer_VBP patients_NNS needing_VBG
        treatment_NN services_NNS ._.
        
        Expanded_NNP care_NN and_CC prevention_NN activities_NNS have_VBP synergistic_JJ
        effects_NNS ._. Continued_VBN effective_JJ treatment_NN ,_, care_NN ,_, and_CC prevention_NN programs_NNS will_MD reduce_VB the_DT
        number_NN of_IN orphans_NNS and_CC vulnerable_JJ children_NNS ,_, reduce_VB mother_NN to_TO child_NN transmission_NN of_IN the_DT
        virus_NN ,_, and_CC improve_VB the_DT lives_NNS of_IN families_NNS and_CC the_DT strength_NN of_IN communities_NNS ._.
        
        Integration_NNP ensures_VBZ that_IN prevention_NN activities_NNS are_VBP not_RB neglected_VBN ._. The_DT
        world_NN has_VBZ a_DT unique_JJ opportunity_NN ,_, as_IN ART_NNP services_NNS are_VBP launched_VBN and_CC expanded_VBN ,_, to_TO
        simultaneously_RB bolster_VB prevention_NN efforts_NNS [_NN 4_CD ]_NN ._. Experience_NN in_IN the_DT United_NNP States_NNPS indicates_VBZ
        that_DT availability_NN of_IN treatment_NN can_MD lead_VB to_TO increased_VB risk_NN behavior_NN [_NN 5_CD ]_NN ._. In_IN addition_NN ,_, the_DT
        improvement_NN in_IN the_DT health_NN ,_, well-being_NN ,_, and_CC longevity_NN of_IN people_NNS living_VBG with_IN AIDS_NNP could_MD
        increase_VB the_DT opportunities_NNS for_IN HIV_NNP transmission_NN ._. Integration_NNP can_MD help_VB reduce_VB these_DT
        potential_JJ negative_JJ impacts_NNS of_IN treatment_NN ._.
        
        Integration_NNP can_MD provide_VB opportunities_NNS to_TO address_VB vulnerable_JJ groups_NNS more_RBR
        effectively_RB ._. A_DT commitment_NN to_TO providing_VBG large-scale_JJ treatment_NN helps_VBZ to_TO focus_VB attention_NN
        on_IN communities_NNS at_IN greatest_JJS risk_NN ,_, particularly_RB in_IN lower_JJR prevalence_NN contexts_NNS ._. This_DT provides_VBZ
        an_DT opportunity_NN to_TO address_VB the_DT prevention_NN and_CC treatment_NN needs_NNS of_IN vulnerable_JJ groups_NNS more_RBR
        effectively_RB ._.
        
        Treatment_NNP resources_NNS can_MD help_VB improve_VB infrastructure_NN for_IN prevention_NN and_CC other_JJ
        health_NN services_NNS ._. The_DT training_NN of_IN health_NN providers_NNS and_CC improvements_NNS in_IN laboratory_NN
        services_NNS ,_, pharmacy_NN ,_, logistics_NNS ,_, commodity_NN management_NN ,_, and_CC health_NN information_NN systems_NNS can_MD
        benefit_VB both_DT treatment_NN and_CC prevention_NN services_NNS ._. Further_RB ,_, in_IN many_JJ countries_NNS ,_, a_DT large_JJ number_NN
        of_IN health-care_NN workers_NNS are_VBP themselves_PRP infected_JJ ._. Treatment_NNP can_MD help_VB to_TO preserve_VB the_DT lives_NNS
        and_CC productivity_NN of_IN these_DT critically_RB needed_VBN AIDS_NNP prevention_NN and_CC treatment_NN workers_NNS ,_, as_RB well_RB
        as_IN those_DT of_IN other_JJ health_NN professionals_NNS ._.
        
        A_DT long-term_JJ decline_NN in_IN AIDS_NNP deaths_NNS may_MD be_VB preventing_VBG new_JJ infections_NNS ._. The_DT
        short-term_JJ decline_NN in_IN AIDS_NNP deaths_NNS is_VBZ driven_VBN by_IN effective_JJ care_NN and_CC treatment_NN programs_NNS ,_, but_CC a_DT
        long-term_JJ decline_NN may_MD be_VB driven_VBN by_IN the_DT prevention_NN of_IN new_JJ infections_NNS ._. Integrated_NNP and_CC
        comprehensive_JJ strategies_NNS are_VBP more_RBR likely_JJ to_TO lead_VB to_TO affordable_JJ ,_, sustainable_JJ programs_NNS ._.
        
        Success_NNP requires_VBZ dramatic_JJ expansion_NN of_IN both_DT ART_NNP and_CC prevention_NN ._. Globally_NNP ,_,
        fewer_JJR than_IN one_CD in_IN five_CD people_NNS at_IN high_JJ risk_NN of_IN infection_NN have_VBP access_NN to_TO proven_VBN HIV_NNP
        prevention_NN interventions_NNS [_NN 6_CD ]_NN and_CC less_JJR than_IN 10_CD %_NN have_VBP access_NN to_TO ART_NNP [_NN 1_CD ]_NN ._. Unless_IN there_EX is_VBZ a_DT
        substantial_JJ increase_NN in_IN commitment_NN and_CC resources_NNS for_IN both_DT prevention_NN and_CC ART_NNP ,_, efforts_NNS to_TO
        control_VB HIV_NNP /_NN AIDS_NNP and_CC mitigate_VB its_PRP$ impact_NN will_MD only_RB meet_VB with_IN partial_JJ and_CC limited_JJ success_NN ._.
        In_IN addition_NN ,_, to_TO increase_VB resources_NNS ,_, intensified_VBN commitment_NN is_VBZ required_VBN to_TO ensure_VB every_DT
        opportunity_NN is_VBZ taken_VBN to_TO integrate_VB prevention_NN and_CC treatment_NN ._. Future_JJ analysis_NN and_CC debate_NN
        should_MD move_VB from_IN comparisons_NNS of_IN prevention_NN and_CC treatment_NN priorities_NNS to_TO a_DT sustained_VBN analysis_NN
        of_IN how_WRB we_PRP can_MD reciprocally_RB integrate_VB and_CC strengthen_VB prevention_NN and_CC care_NN and_CC use_VB every_DT
        opportunity_NN provided_VBN by_IN one_CD to_TO reinforce_VB the_DT other_JJ ._. We_PRP must_MD focus_VB on_IN the_DT development_NN of_IN
        training_NN ,_, monitoring_VBG ,_, and_CC quality_NN assurance_NN systems_NNS that_WDT ensure_VBP that_DT prevention_NN and_CC care_NN
        are_VBP integrated_VBN whenever_WRB possible_JJ ._.
        
        The_DT results_NNS of_IN Salomon_NNP and_CC colleagues_NNS '_POS model_NN need_VBP to_TO be_VB
        validated_JJ ._. Further_RB operational_JJ research_NN is_VBZ needed_VBN to_TO validate_NN the_DT findings_NNS of_IN this_DT
        study_NN ._.
      
    
  
